Prognostic model for predicting overall survival in children and adolescents with rhabdomyosarcoma

BMC Cancer

Volumn 14, Issue 1, 2014, Pages

  Yang, Limin ^a   Takimoto, Tetsuya ^a   Fujimoto, Junichiro ^a  

^a NATIONAL CENTER FOR CHILD HEALTH AND DEVELOPMENT   (Japan)

Author keywords

Cancer; Nomogram; Overall survival; Rhabdomyosarcoma

Indexed keywords

ADOLESCENT; ADULT; AGE DISTRIBUTION; ARTICLE; CANCER MORTALITY; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CHILD; COHORT ANALYSIS; FEMALE; HISTOLOGY; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; NOMOGRAM; OVERALL SURVIVAL; PREDICTION; RHABDOMYOSARCOMA; RISK FACTOR; STATISTICAL MODEL; SURVIVAL RATE; SURVIVAL TIME; TUMOR VOLUME; AGE; MORTALITY; NEWBORN; PATHOLOGY; PRESCHOOL CHILD; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; SURVIVAL; TREATMENT OUTCOME;

ADOLESCENT; AGE FACTORS; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; MALE; NEOPLASM STAGING; NOMOGRAMS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RHABDOMYOSARCOMA; SURVIVAL ANALYSIS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 84906930187     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-14-654     Document Type: Article

References (25)

1. Miller RW, Young JL, Novakovic B. Childhood cancer. Cancer 1995, 75(1 Suppl):395-405.
2. Ries L, Smith M, Gurney J, Linet M, Tamra T, Young J, Bunin G. Cancer Incidence and Survival among Children and Adolescents: United States SEER Program 1975-1995 1999, Bethesda, MD: National Cancer Institute, SEER Program, NIH Pub. No. 99-4649.
3. Crist W, Gehan EA, Ragab AH, Dickman PS, Donaldson SS, Fryer C, Hammond D, Hays DM, Herrmann J, Heyn R, Jones PM, Lawrence W, Newton W, Ortega J, Raney RB, Ruymann FB, Tefft M, Webber B, Wiener E, Wharam M, Vietti TJ, Maurer HM. The Third Intergroup Rhabdomyosarcoma Study. J Clin Oncol 1995, 13(3):610-630.
4. Pappo AS, Shapiro DN, Crist WM, Maurer HM. Biology and therapy of pediatric rhabdomyosarcoma. J Clin Oncol 1995, 13(8):2123-2139.
5. Surveillance, Epidemiology, and End Results (SEER) Program SEER*Stat Database: Incidence - SEER 9 Regs Research Data, Nov 2011 Sub (1973-2010) <Katrina/Rita Population Adjustment> - Linked To County Attributes - Total U.S., 1969-2010 Counties, National Cancer Institute, DCCPS, Surveillance Research Program, Surveillance Systems Branch, released April 2013, based on the November 2012 submission [http://www.seer.cancer.gov].
6. Punyko JA, Mertens AC, Baker KS, Ness KK, Robison LL, Gurney JG. Long-term survival probabilities for childhood rhabdomyosarcoma. A population-based evaluation. Cancer 2005, 103(7):1475-1483. 10.1002/cncr.20929, 15712283.
7. Barnholtz-Sloan JS, Yu C, Sloan AE, Vengoechea J, Wang M, Dignam JJ, Vogelbaum MA, Sperduto PW, Mehta MP, Machtay M, Kattan MW. A nomogram for individualized estimation of survival among patients with brain metastasis. Neurooncol 2012, 14(7):910-918.
8. Lee CM, Szabo A, Shrieve DC, Macdonald OK, Gaffney DK. Frequency and effect of adjuvant radiation therapy among women with stage I endometrial adenocarcinoma. JAMA 2006, 295(4):389-397. 10.1001/jama.295.4.389, 16434629.
9. Sultan I, Qaddoumi I, Yaser S, Rodriguez-Galindo C, Ferrari A. Comparing adult and pediatric rhabdomyosarcoma in the surveillance, epidemiology and end results program, 1973 to 2005: an analysis of 2,600 patients. J Clin Oncol 2009, 27(20):3391-3397. 10.1200/JCO.2008.19.7483, 19398574.
10. rms: Regression Modeling Strategies. R package version 4.2-0 [http://CRAN.R-project.org/package=rms].
11. Harrell FE, Lee KL, Mark DB. Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med 1996, 15(4):361-387. 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4, 8668867.
12. R Core Team R: A language and environment for statistical computing Vienna, Austria: R Foundation for Statistical Computing, [http://www.R-project.org/.], R Core Team.
13. Porter CR, Suardi N, Capitanio U, Hutterer GC, Kodama K, Gibbons RP, Correa R, Perrotte P, Montorsi F, Karakiewicz PI. A nomogram predicting prostate cancer-specific mortality after radical prostatectomy. Urol Int 2010, 84(2):132-140. 10.1159/000277588, 20215815.
14. Eastham JA, Kelly WK, Grossfeld GD, Small EJ. Cancer, Leukemia Group B; Cancer and Leukemia Group B (CALGB) 90203: a randomized phase 3 study of radical prostatectomy alone versus estramustine and docetaxel before radical prostatectomy for patients with high-risk localized disease. Urology 2003, 62(Suppl 1):55-62.
15. Stephenson AJ, Scardino PT, Kattan MW, Pisansky TM, Slawin KM, Klein EA, Anscher MS, Michalski JM, Sandler HM, Lin DW, Forman JD, Zelefsky MJ, Kestin LL, Roehrborn CG, Catton CN, DeWeese TL, Liauw SL, Valicenti RK, Kuban DA, Pollack A. Predicting the outcome of salvage radiation therapy for recurrent prostate cancer after radical prostatectomy. J Clin Oncol 2007, 25(15):2035-2041. 10.1200/JCO.2006.08.9607, 2670394, 17513807.
16. Rouzier R, Pusztai L, Delaloge S, Gonzalez-Angulo AM, Andre F, Hess KR, Buzdar AU, Garbay JR, Spielmann M, Mathieu MC, Symmans WF, Wagner P, Atallah D, Valero V, Berry DA, Hortobagyi GN. Nomograms to predict pathologic complete response and metastasis-free survival after preoperative chemotherapy for breast cancer. J Clin Oncol 2005, 23(33):8331-8339. 10.1200/JCO.2005.01.2898, 16293864.
17. Brennan MF, Kattan MW, Klimstra D, Conlon K. Prognostic nomogram for patients undergoing resection for adenocarcinoma of the pancreas. Ann Surg 2004, 240(2):293-298. 10.1097/01.sla.0000133125.85489.07, 1356406, 15273554.
18. Kattan MW, Karpeh MS, Mazumdar M, Brennan MF. Postoperative nomogram for disease-specific survival after an R0 resection for gastric carcinoma. J Clin Oncol 2003, 21(19):3647-3650. 10.1200/JCO.2003.01.240, 14512396.
19. Yang L, Shen W, Sakamoto N. Population-based study evaluating and predicting the probability of death resulting from thyroid cancer and other causes among patients with thyroid cancer. J Clin Oncol 2013, 31(4):468-474. 10.1200/JCO.2012.42.4457, 23270002.
20. Kutikov A, Egleston BL, Wong YN, Uzzo RG. Evaluating overall survival and competing risks of death in patients with localized renal cell carcinoma using a comprehensive nomogram. J Clin Oncol 2010, 28(2):311-317. 10.1200/JCO.2009.22.4816, 2815719, 19933918.
21. Kattan MW, Leung DH, Brennan MF. Postoperative nomogram for 12-year sarcoma-specific death. J Clin Oncol 2002, 20(3):791-796. 10.1200/JCO.20.3.791, 11821462.
22. Gronchi A, Miceli R, Shurell E, Eilber FC, Eilber FR, Anaya DA, Kattan MW, Honore C, Lev DC, Colombo C, Bonvalot S, Mariani L, Pollock RE. Outcome prediction in primary resected retroperitoneal soft tissue sarcoma: histology-specific overall survival and disease-free survival nomograms built on major sarcoma center data sets. J Clin Oncol 2013, 31(13):1649-1655. 10.1200/JCO.2012.44.3747, 23530096.
23. Chisholm JC, Marandet J, Rey A, Scopinaro M, de Toledo JS, Merks JH, O'Meara A, Stevens MC, Oberlin O. Prognostic factors after relapse in nonmetastatic rhabdomyosarcoma: a nomogram to better define patients who can be salvaged with further therapy. J Clin Oncol 2011, 29(10):1319-1325. 10.1200/JCO.2010.32.1984, 21357778.
24. Zini L, Cloutier V, Isbarn H, Perrotte P, Capitanio U, Jeldres C, Shariat SF, Saad F, Arjane P, Duclos A, Lattout JB, Montorsi F, Karakiewicz PI. A simple and accurate model for prediction of cancer-specific mortality in patients treated with surgery for primary penile squamous cell carcinoma. Clin Cancer Res 2009, 15(3):1013-1018. 10.1158/1078-0432.CCR-08-1888, 19188173.
25. Komdeur R, Klunder J, van der Graaf WT, van den Berg E, de Bont ES, Hoekstra HJ, Molenaar WM. Multidrug resistance proteins in rhabdomyosarcomas: comparison between children and adults. Cancer 2003, 97(8):1999-2005. 10.1002/cncr.11259, 12673730.